Exchange Announcement • 19 Dec 2025 19:45
Exchange Announcement • 04 Dec 2025 16:49
Exchange Announcement • 19 Nov 2025 19:52
Exchange Announcement • 14 Nov 2025 22:11
Exchange Announcement • 06 Nov 2025 19:30
Search or
𝛼SK
𝛼SKENTITY
BeiGene (6160 HK)
BeiGene (6160 HK)
439
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
morex